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ABSTRACT: While there has been extensive research on the link between depression and cardiovascular disease, few 
reviews have summarized the array of findings. In this literature review, we examined approximately 50 clinical papers 
and research studies to determine if reducing depression could reduce the risk of having a cardiovascular incident and 
if reducing the severity of cardiovascular disease could reduce depression. We identified two major mechanisms through 
which depression affects the cardiovascular system. We present evidence that depression and cardiovascular disease 
may have a reciprocal relationship. For instance, depression is as much of a risk factor for heart disease as smoking and 
hypertension. Further, depression is 20% more common in patients after a major cardiac event like a myocardial 
infarction. In addition, we examine how treating depression could reduce the risk of developing a cardiovascular 
disease.
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INTRODUCTION
Mental illness not only influences the psychological 
aspects of the body, but it can also negatively impact the 
physical body as a system. For example, depression is a 
debilitating condition and the leading cause of disability 
worldwide (Mata D, 2015). This disorder affects an 
individual’s mood with a persistent feeling of sadness, 
agitation, social isolation, and suicidal thoughts. In 
addition, it could have physical implications in terms 
of sleep, energy and appetite disturbance (Health 
Guide, 2019). Mental illnesses can affect the physical 
fitness of individuals. For instance, individuals with 
depression may experience reduced energy and lack of 
motivation. Further, a study of 51 hospitalized depressive 
patients showed a correlation between the length of the 
depressive episode and poorer physical performance 
(Voderholzer U., 2011). This study demonstrates how 
mental health has an impact in the entire body, including 
the cardiovascular system.
Major depression is set to become the leading cause 
of disability worldwide by the year 2030 (Khalid 
Faroog, Asghar and Kanwal, 2017). It is established 
that depression is more prevalent in people who suffer 
major cardiac events. Depression influences people’s 
behaviors and results in abnormal functioning of the 
cardiovascular system. Currently, cardiovascular disease 
is the number one cause of death globally; more people 
die annually from cardiovascular disease than from 
any other cause (World Health Organization, 2017). 
Studies have suggested a possible reciprocal relationship 
between the two illnesses. The presence of cardiovascular 
disease in patients with depression, and, conversely, the 
development of depression after a cardiac disease are 
common. For instance, patients with heart failure and 
depression have an increased risk of being readmitted 
by heart failure exacerbation and, by consequence, suffer 
a significant increase in mortality risk (Pozuelo, 2018; 
Jiang, 2007). A study conducted on 374 patients with 
congestive heart failure showed that patients with major 
depression had higher readmission and mortality rates 
compared to patients with mild or no depression. Also, 
these patients were twice more likely to be readmitted or 
die within three months to one year after a hospitalization 
than non-depressed patients ( Jiang, 2001). Depression 
can cause autonomic dysregulation, hyperproduction of 
cortisol, prothrombotic and proinflammatory states that 
are commonly seen in the development of heart failure 
(Silver, 2010). In addition, symptoms of depression are 
three times more common in patients after an acute heart 
attack than in the general population (Gebska, 2016). 
Despite the overwhelming evidence of this relationship, 
these diseases are rarely treated together. Preventive 
measures should be taken when one of the diseases is 
present.
Treatment for depression has been shown to reduce 
the risk of developing cardiovascular diseases. The 
combination of pharmacological and psychological 
treatments appears to be effective in reducing depressive 
symptoms in patients with cardiac disease and has 
been shown to have a positive effect during recovery 
after a major cardiac event. We seek to examine 
the possible relationship between depression and 
cardiovascular disease. Our inquiry explores whether 
mitigating depression could decrease the risk of having 
a cardiovascular incident and if reducing the severity of 
cardiovascular disease could reduce depression.
METHODS
To investigate the relationship between depression and 
cardiovascular disease, a literature review was conducted. 
PubMed, the UCF Library database, and Google Scholar 
were searched for clinical papers and research studies 
pertaining to depression and cardiovascular disease. Key 
words such as depression, cardiovascular disease, heart 
disease, hypertension, arrhythmias, and stress were put 
into each database’s respective search engine. Articles 
containing these selected keywords were collected, 
analyzed for their relevance, and then selected for 
inclusion. The searches were limited to studies reported 
in English between 1987 and 2019.
FINDINGS
Depression and Cardiovascular disease: a bidirectional 
relationship
Depression is about twice as likely in people with 
heart disease compared to the general population and, 
similarly, people with depression present a higher risk of 
developing heart disease (Harvard Heart Letter, 2016). 
These figures indicate that the relationship between 
depression and cardiovascular disease is bidirectional.
 
There is about an 80% increased risk of developing a 
heart condition with depression, even if the patient 
doesn’t present a history of cardiovascular disease 
(Chaddha, Robinson, Kline-Rogers, Alexandris-
Souphis, & Rubenfire, 2016). In addition, depression 
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after a heart attack is common, especially in patients with 
drastic procedures such as a coronary bypass. Procedures 
like this have extensive periods of recovery and can be 
stressful. This stress has been shown to take a toll on 
the patient’s mental health. After surgery, it is common 
for patients to have trouble sleeping and present with 
fatigue; these symptoms are commonly found in patients 
with depression (Harvard Mental Health Letter, 2009).
How might depression promote cardiovascular disease?
The effect of depression on the body and physical health
The American Heart Association lists depression as 
a risk factor after a heart attack and as an accelerator 
for atherosclerosis. One of the main reasons depression 
contributes to the increased risk for cardiovascular 
disease is the negative effects it has on patients’ lifestyles. 
Depressive symptoms include anxiety, fatigue, anhedonia 
(loss of interest in previously enjoyable activities), 
and hopelessness (Lazarus, Newton, Cohler, Lesser, 
& Schweon, 1987). Due to some of these symptoms, 
individuals with depression tend to be less physically 
active than non-depressed individuals (Paluska & 
Schwenk, 2012). A study conducted on 106 patients, 
among whom 48 were depressed, showed that 1/5 of the 
depressed patients were initially motivated to start regular 
physical activity. Only 1/4 of these patients completed the 
whole program. In comparison all nondepressed patients 
completed the program. The researchers hypothesized 
that a possible reason for this result was that depression 
reduces adherence to exercise regimes. Further, all 
patients who continued with physical activity reported 
their mood was better, even the depressed patients (Suija, 
et al., 2009).
Furthermore, a study conducted on 3,486 individuals 
concluded that depressed individuals are more likely 
to crave sugar and carbohydrates (Akbaraly, Brunner, 
Ferrie, & Marmot, 2018). These types of foods could 
provide a short term benefits, such as comfort, but in 
the long term, a high level of sugar and carbohydrates 
in the diet increases the risk for chronic conditions 
including diabetes, cancer, cardiovascular disease, and 
more (Akbaraly, Brunner, Ferrie, & Marmot, 2018). 
Another study showed that men are more susceptible 
to the effects of sugars on mental health. The study 
concluded that men who ate 67 grams or more of sugar 
daily were 23% more likely to develop depression after 
five years. The researchers did not find any association 
between the amount of sugar ingested and incidents of 
depression in women. Although, higher intakes of sugar 
were correlated to recurrent depression in both sexes 
(Knuppel, Shipley, Llewellyn, & Brunner, 2017). 
Depressed individuals may consume alcohol or engage 
in substance abuse to improve their mood or escape 
feeling of sadness, despair or guilt. This method of self-
medicating can make depressive episodes more severe 
by increasing their frequency and intensity (American 
Addiction Center, 2020). Statistically, depressed 
individuals are more likely to report substance abuse than 
individuals without depression. Alcohol dependence is 
also two times greater in individuals with a history of 
depression (Currie, 2005). The use of depressants like 
alcohol can increase feelings of sadness and fatigue. A 
study conducted on the comorbidity of major depression 
with substance use showed that drug dependence is 
four times more prevalent in depressed individuals 
and increases the chances of having suicidal thoughts. 
In addition, substance abuse increased the prevalence 
of depression to 17% (Currie, 2005). Substance abuse 
increases the severity of the mood disorders by increasing 
the levels of stress experienced by the individual (Hasin 
D, 2002). This stress affects the heart and increases the 
risk of developing cardiovascular diseases. 
In general, people with low physical activity, unbalanced 
diets, and unhealthy substance dependence are more likely 
to develop major depression and heart-related conditions 
(Cabello, et al., 2017). A study conducted by Bonnet, 
Irving and Nony showed that depressive symptoms 
associated with unhealthy lifestyles are more common 
in hypertensive patients. The presence of depressive 
symptoms was significantly associated with unhealthy 
diet practices such as high caloric intake (Bonnet, Irving, 
Nony, Berthezene, & Moulin, 2005). This association 
also included a decrease in physical activity and increased 
smoking habits. The study showed that the prevalence of 
depression was 6% higher in woman than in men (Imran 
Shuja Khawaja, 2009). This gender gap was attributed 
to unequal power and status, work overload and abuse 
that women are more susceptible to experiencing (Mayo 
Clinic, 2020). 
Depression on the biological mechanisms of 
cardiovascular disease
The association between cardiovascular disease and 
depression influences the normal physiological 
processes of the body.  Specifically, the activation of 
the sympathetic nervous system and stress pathways 
13.1: 1-10
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are linked to unfavorable outcomes for a patient at 
risk for cardiovascular disease. Also, the psychological 
stress experienced by people with depression can 
cause deregulation of the hypothalamic-pituitary-
adrenal (HPA) axis (Chaddha, Robinson, Kline-
Rogers, Alexandris-Souphis, & Rubenfire, 2016). The 
activation of the sympathetic nervous system affects 
the cardiovascular system directly through the “fight or 
flight” response. During stress, oxygen demand increases. 
The body reacts by releasing catecholamines, stress 
hormones that constrict the blood vessels, reduce blood 
flow, and increase heart rate. This reaction is known as 
mental-stress-induced myocardial ischemia (MSIMI). 
Furthermore, a study conducted on 98 patients 
hospitalized for acute myocardial infarction showed a 
positive association between depressive symptoms and 
ischemia.  The study evaluated both somatic and cognitive 
depressive symptoms. Further, patients with coronary 
artery disease showed an increased inflammatory 
response to mental stress. This inflammation showed 
a correlation with abnormal coronary microvascular 
function, suggesting a possible mechanism of mental 
stress-induced ischemia ( Jingkai Wei, 2014).
In depressed and anxious individuals, this response 
may become constant. The high dose of catecholamines 
may cause necrotic lesions in the myocardium. These 
lesions are usually accompanied with inflammation and 
fibrous scarring. Further, they may potentially destroy 
the elastic lamellas and atrophy the wall of large vessels 
(Haft, 1974).This damage might lead to conditions like 
atherosclerosis. The basic mechanism for this condition 
involves the lipid accumulation and inflammatory 
activation in the vascular wall (Zmyslowski & Szterk, 
2017). The damage to the laminar flow in shear stress 
on the arterial wall triggers the accumulation of lipids 
and fibrous elements in the arteries. This process, 
known as atherosclerosis, is the primary cause of heart 
disease and stroke (Lusis, 2000). These complications 
can make the heart more susceptible to signals such as 
changes in heartrate. This deregulation may contribute 
to the development of serious heart conditions such 
as hypertension, arrhythmias, platelet activation, and 
coronary heart disease (Dhar & Barton, 2016).
Stress is related to the cardiovascular system and is part of 
the proper functioning of the nervous system. Concerns 
may arise when stress is constant, as this condition 
affects behaviors and factors that increase the risk for 
heart disease. Mental stress is one of the many cognitive 
symptoms that people with depression suffer from. The 
induced activation of the HPA axis by depression and 
the stress associated with it increases the release of stress 
hormones like cortisol (Chaddha, Robinson, Kline-
Rogers, Alexandris-Souphis, & Rubenfire, 2016). In 
small quantities, cortisol prepares the body for physical 
and emotional stress. In depressed patients, however, 
cortisol production becomes problematic due to the 
prolonged stress. Elevated levels of cortisol increase 
blood sugar, low high-density lipoprotein, and blood 
pressure. Further, high cortisol levels reduce the ability 
of the body to fight infections, and increase fat storage in 
the body (Dienes, Hazel, & Hammen, 2019).  
Hypertension is a common condition that can have 
long-term effects on the body. Uncontrolled high blood 
pressure increases the risk of serious health problems. 
Hypertension is often triggered and maintained by 
mental stress. Stress increases the release and reduces the 
uptake of norepinephrine (Delgado & Moreno, 2000). 
Norepinephrine is a hormone and a neurotransmitter 
that plays a role in circadian rhythms, attention, emotions 
and memory. Increased levels of norepinephrine are 
linked with panic attacks, elevated blood pressure, and 
hyperactivity, while low levels cause fatigue, lack of 
concentration and sometimes depression (Delgado 
& Moreno, 2000). Elevated levels of norepinephrine 
have been found in the plasma and the cerebrospinal 
fluid of depressed patients (Dhar & Barton, March 
2016). Further, a study conducted on 45 individuals 
with chronic heart failure showed increased mortality 
in patients suffering from major depression or with 
norepinephrine plasma levels 40% greater than those of 
the control group (Gold, 2005). Psychological distress 
due to severe anxiety, constant stress, and recurring 
depression can result in the release of epinephrine, 
which also contributes to the increase of blood pressure 
and constricts the arteries. During stress, the body 
releases epinephrine, which triggers the “fight or flight” 
response (Hormone Health, 2015). Repeated release of 
epinephrine may lead to plaque disruption, myocardial 
infarction, and, in more chronic cases, may cause an 
aortic rupture (Gebska, 2016). Prolonged mental stress 
has been shown to increase platelet activation and 
endothelial dysfunction; both conditions are considered 
early signs of cardiovascular deterioration (Grippo & 
Johnson, 2009). Depression is also linked to low-grade 
inflammation and is implicated with increased platelet 
activity. This condition can increase the probability of the 
thrombus formation and the rupture of cholesterol-filled 
plaque (Chaddha, Robinson, Kline-Rogers, Alexandris-
Souphis, & Rubenfire, 2016). The constant production 
13.1: 1-10
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of stress hormones due to depression activates 
platelets, making them more likely to form clots in the 
bloodstream. In fact, depression is associated with raised 
platelet serotonin levels, promoting clotting (American 
Psychiatric Association, 1994).
Cytokines are known for causing changes to the central 
nervous system. Studies have examined the increase of 
pro-inflammatory cytokines in elderly depressed patients 
and in women experiencing post-partum depression. In 
a study conducted by Faroog et al., cytokine levels were 
directly proportional to the severity of the depression 
(Khalid Faroog, Asghar and Kanwal, 2017). The cytokine 
Interleukin-6 (IL-6) has been linked to stress-related 
disorders such as depression and anxiety. The elevated 
level of IL-6 in the blood of patients with depression is 
caused by chronic stress. Evidence suggests that increases 
of IL-6 also increase stress sensitivity (Hodes, Menard, 
& Russo, 2016). In addition, there is evidence that 
inflammation due to IL-6 plays a role in the development 
of coronary heart disease and atherosclerosis. Elevated 
levels of cytokines are associated with an increase in 
blood viscosity and an increase in platelet number activity. 
Further, IL-6 stimulates activation of the HPA axis; this 
activation is associated with vascular damage, higher risk 
of obesity, hypertension, and insulin resistance (Yudkin, 
Kumari, Humphries, & Mohamed-Ali, 2000).
Depression after a Heart Attack
The American Heart Association recommends patients 
who have suffered a heart attack be screened for 
depressive symptoms. Major depression is 20% more 
common in patients after a heart attack; during recovery, 
20% of the patients might suffer from mild depression 
(Woolston, 2019). The combination of major life 
stressors contributes to the development of depression. 
The emotional distress accompanied by the recovery 
from a heart attack increases the risk of another heart 
attack or any related cardiovascular disease (Williams, 
2011). Once depression is present in the patients who 
suffered a major cardiac event, it is expected for them 
to still present depressive symptoms 4 months post-
discharge (Dhar & Barton, March 2016).
Treating the Disorder 
Depression impacts patients’ health, family members 
and quality of life. Treating depression alleviates the 
depressive symptoms affecting the body and the lifestyle 
of the individual. Additionally, treatment decreases the 
constant stress and anxiety that triggers the release of 
stress hormones and disrupts the balance of the HPA 
axis. Treatment has demonstrated improvements in 
long-term cardiovascular health and increase quality of 
life. Further, medications, therapy and non-medication 
interventions such as exercise and meditation have 
been shown to reverse the cardiovascular changes due 
to the mental distress (Levine, 2017; Ornish, 1997). 
Patients suffering from depression who haven’t been 
diagnosed with cardiovascular diseases can benefit from 
regular exercise, better nutrition, and stress management 
techniques. These factors decrease the risk of developing 
recurrent depression and cardiovascular disease.   
Various antidepressants are available to manage 
symptoms of depression, but it is important to 
evaluate the cardiovascular risk before prescribing 
( Jiang & Davidson, 2005). The production of effective 
medications for the treatment of depression and 
patients with cardiovascular disease has increased 
over time. Some examples of antidepressants include 
Table 1. List of possible mechanisms that may lead to cardiovascular disease
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SSRIs (selective serotonin reuptake inhibitors), SNRIs 
(serotonin-norepinephrine reuptake inhibitors), TCAs 
(tricyclic antidepressants), MAOIs (monoamine oxidase 
inhibitors) and antidepressants that work by other 
mechanisms (Rosenberg, 2014). Extensive research 
has been conducted to develop safe antidepressants for 
cardiac patients. One of the largest randomized trials 
in this subject is the Sertraline Antidepressant Heart 
Attack Randomized Trial (SADHART). The study 
was conducted with 369 participants who developed 
depression after a hospitalization for acute coronary 
syndrome. Randomly selected individuals took either 
an SSRI or a placebo. The results suggested that SSRIs 
protected the individuals by reducing platelet activation 
(Glassman, O'Connor, & Califf, 2002).
However, no data was found on how psychotherapy by 
itself affects the outcome of cardiovascular disease in 
patients with depression. According to our findings, no 
study has examined whether psychological treatment 
for depression reduces the risk for cardiovascular 
disease (Steward, Perkins, & Callahan, 2014). However, 
other studies have concluded that the combination of 
medication and psychological treatment may reduce 
    CVD= Cardiovascular Disease; HF=Heart Failure
Table 2. Summary of preventive studies of depression and cardiac conditions. 
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anxiety, stress and depression; therefore, psychological 
treatment may decrease the risk of developing 
cardiovascular disease (Dhar & Barton, 2016). 
Research on Prevention 
The connection between cardiovascular disease and 
depression is evident. The relationship between these 
two conditions increases the intensity and severity of 
each. Evidence from observational studies demonstrates 
that treating depression may prevent cardiac events. 
A study conducted by Steward, Perkins, and Callahan 
focused on the treatment of depression for high-risk 
cardiac patients. Their results showed that treatment 
reduced the risk of having a chronic cardiac condition to 
50%, see Table 2 (Steward, Perkins, & Callahan, 2014). 
Their finding indicated that treating depression reduces 
the risk of developing cardiovascular events, such as 
strokes and coronary heart disease. In addition, the data 
suggests that complementing recovery with a preventive 
depression mindset improves the cardiovascular 
prognosis (Rosenberg, 2014). 
CONCLUSION
The bidirectional correlation between cardiovascular 
disease and depression should be a present concern 
when treating patients with one of these conditions. 
Preventive measures for these disorders have shown 
positive outcomes. Those suffering from depression have 
a higher risk of developing cardiovascular diseases due to 
the constant production of stress hormones. The constant 
stress and anxiety patients may experience during 
depression could affect the physiological mechanism 
of the HPA axis. These changes in the homeostatic 
and neuroendocrine function increase the risk of 
developing cardiovascular diseases. At the same time, 
the manifestation of depressive symptoms could affect 
the individual’s lifestyle. If this condition is accompanied 
by an unbalanced diet, low physical activity, and 
unhealthy substance dependence, the risk of developing 
cardiovascular diseases increases. Further, cardiovascular 
conditions such as heart attacks and heart failure are 
usually accompanied by emotional distress. These events 
may increase the probability of developing depressive 
symptoms, which complicates the recovery process. 
 
The combination of psychotherapy and antidepressants 
has shown positive outcomes by increasing quality 
of life. Non-medical interventions such as exercise, 
meditation, and breathing exercises have also been 
shown to increase heart and mental health. During 
treatment for either condition, studies suggest that 
having a preventive mentality can improve patients’ 
psychological and physiological condition. To optimize 
patients’ outcomes and prevent the comorbidity of 
depression and cardiovascular disease, it is important for 
patients to discuss mental health with their doctors. The 
stigma around this conversation is what causes mental 
illness to go undiagnosed. Further, future studies could 
examine if the psychological and clinical treatments for 
depression can decrease the probability of developing 
cardiovascular diseases. Understanding the comorbidity 
of these conditions could also encourage future clinical 
preventive measures that decrease the intensity of 
depressive symptoms and, by consequence, decrease the 
risk of developing cardiovascular disease. 
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